Zobrazeno 1 - 10
of 214
pro vyhledávání: '"W. W. de Herder"'
Autor:
Rocio Garcia-Carbonero, Piero Ferolla, Marianne Pavel, Nicola Fazio, Martyn Caplin, C. Lombard-Bohas, Eric Lim, Andrea Frilling, J.-Y. Scoazec, Eric Baudin, Ulrich Knigge, P.L. Filosso, Alfredo Berruti, Dieter Hörsch, W. W. de Herder, Anders Sundin, Catharina M. Korse
Publikováno v:
Annals of Oncology, 32(4), 439-451. Elsevier Ltd.
Autor:
Alfredo Berruti, W. W. de Herder, Eric Baudin, Rocio Garcia-Carbonero, Catharina M. Korse, Anders Sundin, A. Frilling, C. Lombard-Bohas, Marianne Pavel, Piero Ferolla, Dieter Hörsch, Nicola Fazio, Ulrich Knigge, P.L. Filosso, Martyn Caplin, J.-Y. Scoazec, Eric Lim
Publikováno v:
Annals of Oncology. 32:1453-1455
Autor:
Ammar Muhammad, F.J. van Kemenade, Esther Korpershoek, A. J. van der Lely, Adrian Daly, W. W. de Herder, Eva C Coopmans, Albert Beckers, Sebastian J C M M Neggers, M. de Haan
Publikováno v:
Endocrine
Endocrine, 68(3), 640-649. Humana Press
Endocrine, 68(3), 640-649. Humana Press
Purpose Germline mutations in the aryl-hydrocarbon receptor interacting protein (AIP) have been identified often in the setting of familial isolated pituitary adenoma (FIPA). To date there is no strong evidence linking germline AIP mutations to other
Autor:
W W, de Herder
Publikováno v:
Journal of endocrinological investigation. 45(10)
Autor:
W W, de Herder
Publikováno v:
Journal of endocrinological investigationReference. 45(6)
Autor:
Boen Liong Kam, Jaap J.M. Teunissen, Johannes Hofland, Tessa Brabander, E. P. Krenning, W. A. van der Zwan, W. W. de Herder, Richard A Feelders
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging, 46(3), 704-717. Springer-Verlag
Therapy with [177Lu-DOTA,Tyr3]octreotate is effective in patients with grade I/II metastasized and/or inoperable bronchial neuroendocrine tumour (NET) or gastroenteropancreatic NET (GEP-NET). In this study, we investigated the efficacy and safety of
Autor:
G. Van Camp, K. Op de Beeck, K Biermann, W. W. de Herder, Timon Vandamme, Marc Peeters, Kimberly Kamp, Matthias Beyens, Gitta Boons, Leo J. Hofland, Patrick Pauwels, Anne Schepers
Publikováno v:
Endocrine-related cancer
Endocrine-Related Cancer, 26(1), 1-12. Bioscientifica Ltd
Endocrine-Related Cancer, 26(1), 1-12. Bioscientifica Ltd
Mutations in DAXX/ATRX, MEN1 and genes involved in the phosphoinositide-3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway have been implicated in pancreatic neuroendocrine neoplasms (pNENs). However, mainly mutations present in the m
Autor:
W. W. de Herder
Publikováno v:
Journal of Endocrinological Investigation, 45(9). Springer International Publishing AG
Publikováno v:
Current Oncology Reports
Purpose of Review Peptide receptor radionuclide therapy (PRRT) with [177Lu-DOTA0,Tyr3] octreotate is an effective and safe second- or third-line treatment option for patients with low-grade advanced gastroenteropancreatic (GEP) neuroendocrine neoplas
Autor:
G. D. Valk, R. S. van Leeuwaarde, M. J. C. van Treijen, T. P. Links, R. P. Peeters, H. J. L. M. Timmers, E. P. M. van der Kleij-Corssmit, O. M. Dekkers, R. A. Feelders, H. R. Haak, N. R. Biermasz, J. Hofland, W. W. de Herder, A. M. Pereira Arias, P. T. A. M. Lips, J. W. A. Smit, C. J. M. Lips, H. W. Kapiteijn, J. Kievit, H. F. ten Kroode
Publikováno v:
Leerboek oncologie ISBN: 9789036824484
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe03fc2766d10a99bee2a9c8c82356ce
https://doi.org/10.1007/978-90-368-2449-1_30
https://doi.org/10.1007/978-90-368-2449-1_30